Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Category Archives: EP and UK Practice
From SLW International: Info on the Unitary Patent and the Unified Patent Court
Guest contribution from SLW International: A short paper with information on the Unitary Patent and the Unified Patent Court can be found here.
Interesting Developments at the EPO
Guest post from Rigel Menard. There are changes at the EPO coming that require the specification to better reflect the allowed claims. In applications in which multiple inventions are disclosed, the new rules seem to be requiring editing the specification … Continue reading
Regeneron v. Kymab – “Sufficiency” and Enablement in the U.K.
Guest post from Paul Cole. Regeneron Pharmaceuticals Inc v Kymab Ltd. [2020] UKSC 27 related to infringement of EP-B-1,360,287 and its divisional EP-B-2264123. The 287 parent related to a method of modifying an endogenous immunoglobulin variable region gene locus in … Continue reading
EPO – New Guidance On Added Subject Matter
A guest post from Paul Cole. Readers will be aware that added subject matter issues have for a long time been a thorny issue for EPO Examination practice. On 7 February 2014 a symposium on EPO practice regarding Art. 123(2) … Continue reading
Posted in EP and UK Practice
Tagged biotechnology law, EPO, intellectual property, ip, Paul Cole, Warren Woessner
Leave a comment